Phio Pharmaceuticals Corp Files For Mixed Shelf Of Upto $100M
Portfolio Pulse from Benzinga Newsdesk
Phio Pharmaceuticals Corp has filed for a mixed shelf offering of up to $100 million, according to an SEC filing.
May 17, 2024 | 8:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Phio Pharmaceuticals Corp has filed for a mixed shelf offering of up to $100 million, which could lead to potential dilution of existing shares and impact stock price.
A mixed shelf offering allows the company to issue various types of securities, which can lead to dilution of existing shares. This often results in a short-term negative impact on the stock price as investors anticipate the potential increase in supply of shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100